Mpox study: vaccine response in outbreaks
Part of Infections clinical trials.
This study looks at how well the mpox vaccine works during outbreaks. It tracks people who may have been exposed, those who have been vaccinated or already had mpox, and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 5 and 80 years old and generally healthy.
- You must be willing to give consent and follow study rules.
- If you may have been exposed to mpox, you must live near an outbreak area or have close contact with someone who tested positive.
- If you have had mpox or the mpox/smallpox vaccine, you must be fully recovered.
- You cannot be pregnant or breastfeeding, or have a bleeding or immune disorder that may affect results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study looks at how your body’s defenses work against mpox (monkeypox), based on blood and health information. You may be eligible if you recently got an mpox vaccine or have had mpox infection and are now out of isolation.
This study tests whether a single dose of the LC16m8 mpox vaccine is safe and works in people living in the Democratic Republic of Congo. It also monitors for side effects and tracks mpox cases to see how well the vaccine protects the community.
This is an observational study that follows people with confirmed monkeypox (mpox) to better understand the illness over time. It may help doctors learn what to expect and improve care, but it does not test a new treatment.
This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.
This study looks at how mpox affects people, how it spreads, and what happens over time. If you are being tested for mpox, you may join to help researchers learn more.
This study is for people in the Democratic Republic of Congo who have been diagnosed with mpox. Researchers want to learn more about how the virus spreads and how it affects people during this outbreak.
Hear when a new Mpox trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.